Advertisement
Canada markets open in 7 hours 39 minutes

  • S&P/TSX

    22,375.83
    +116.63 (+0.52%)
     

  • S&P 500

    5,214.08
    +26.41 (+0.51%)
     

  • DOW

    39,387.76
    +331.36 (+0.85%)
     

  • CAD/USD

    0.7307
    -0.0004 (-0.05%)
     

  • CRUDE OIL

    79.87
    +0.61 (+0.77%)
     

  • Bitcoin CAD

    85,901.62
    +1,679.18 (+1.99%)
     

  • CMC Crypto 200

    1,348.92
    +48.82 (+3.76%)
     

  • GOLD FUTURES

    2,362.30
    +22.00 (+0.94%)
     

  • RUSSELL 2000

    2,073.63
    +18.49 (+0.90%)
     

  • 10-Yr Bond

    4.4490
    -0.0430 (-0.96%)
     

  • NASDAQ futures

    18,232.00
    +17.50 (+0.10%)
     

  • VOLATILITY

    12.69
    -0.31 (-2.38%)
     

  • FTSE

    8,381.35
    +27.30 (+0.33%)
     

  • NIKKEI 225

    38,156.75
    +82.77 (+0.22%)
     

  • CAD/EUR

    0.6779
    +0.0001 (+0.01%)
     

Today’s Research Reports on Knight Therapeutics, Crescita Therapeutics, CanniMed Therapeutics and Cipher Pharmaceuticals

ACCESSWIRE

NEW YORK, NY / ACCESSWIRE / March 22, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://rdinvesting.com and get exclusive access to our numerous research reports and market updates.

RDI has Initiated Coverage Today on:

Knight Therapeutics Inc.
https://rdinvesting.com/news/?ticker=GUD.TO

Crescita Therapeutics Inc.
https://rdinvesting.com/news/?ticker=CTX.TO

CanniMed Therapeutics Inc.
https://rdinvesting.com/news/?ticker=CMED.TO

Cipher Pharmaceuticals Inc.
https://rdinvesting.com/news/?ticker=CPH.TO

ADVERTISEMENT

Knight Therapeutics' stock had no change Wednesday, to close the day at $7.77. The stock recorded a trading volume of 202,315 shares, which was above its three months average volume of 198,295 shares. In the last year, Knight Therapeutics' shares have traded in a range of 7.38 - 10.75. The stock is currently trading 27.72% below its 52 week high. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $7.74 is below its 200-day moving average of $8.11. Shares of Knight Therapeutics are trading at a Price to Earnings ratio of 64.75. Shares of Knight Therapeutics have fallen approximately 6.50 percent year-to-date.

Access RDI's Knight Therapeutics Inc. Research Report at:
https://rdinvesting.com/news/?ticker=GUD.TO

On Wednesday, shares of Crescita Therapeutics recorded a trading volume of 25,000 shares, which was below the three months average volume of 31,890 shares. The stock ended the day 2.00% higher at 0.51. The stock is currently trading 56.03% below its 52-week high with a 52-week trading range of 0.48 - 1.16. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $0.60 is below its 200-day moving average of $0.62. Shares of Crescita Therapeutics have fallen approximately 3.03 percent year-to-date.

Access RDI's Crescita Therapeutics Inc. Research Report at:
https://rdinvesting.com/news/?ticker=CTX.TO

CanniMed Therapeutics' stock moved 1.52% lower Wednesday, to close the day at $35.68. The stock recorded a trading volume of 61,696 shares, which was below its three months average volume of 543,706 shares. In the last year, CanniMed Therapeutics' shares have traded in a range of 7.32 - 46.00. The share price has gained 387.43% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $35.78 is greater than its 200-day moving average of $22.37. Shares of CanniMed Therapeutics are trading at a Price to Earnings ratio of 249.51. Shares of CanniMed Therapeutics have gained approximately 58.23 percent year-to-date.

Access RDI's CanniMed Therapeutics Inc. Research Report at:
https://rdinvesting.com/news/?ticker=CMED.TO

On Wednesday, shares of Cipher Pharmaceuticals recorded a trading volume of 24,510 shares, which was below the three months average volume of 31,036 shares. The stock ended the day 4.08% lower at 3.53. The stock is currently trading 38.61% below its 52-week high with a 52-week trading range of 3.53 - 5.75. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $4.02 is below its 200-day moving average of $4.46. Shares of the company are trading at a Price to Earnings ratio of 21.66. Shares of Cipher Pharmaceuticals have fallen approximately 27.96 percent year-to-date.

Access RDI's Cipher Pharmaceuticals Inc. Research Report at:
https://rdinvesting.com/news/?ticker=CPH.TO

Our Actionable Research on Knight Therapeutics Inc. (TSX:GUD.TO), Crescita Therapeutics Inc. (TSX:CTX.TO), CanniMed Therapeutics Inc. (TSX:CMED.TO) and Cipher Pharmaceuticals Inc. (TSX:CPH.TO) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com